Home > Publications Database > Can vigorous physical activity mitigate the effect of systemic inflammation on cognitive performance? Results from a large older community dwelling population in The Netherlands. > print

001     282554
005     20251218103441.0
024 7 _ |a 10.1177/13872877251386480
|2 doi
024 7 _ |a pmid:41100846
|2 pmid
024 7 _ |a pmc:PMC12647380
|2 pmc
024 7 _ |a 1387-2877
|2 ISSN
024 7 _ |a 1875-8908
|2 ISSN
037 _ _ |a DZNE-2025-01317
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Fink, Anne
|0 P:(DE-2719)2241493
|b 0
|e First author
245 _ _ |a Can vigorous physical activity mitigate the effect of systemic inflammation on cognitive performance? Results from a large older community dwelling population in The Netherlands.
260 _ _ |a Amsterdam
|c 2025
|b IOS Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1764680431_28227
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a BackgroundElevated systemic inflammation is associated with poorer cognitive function, while vigorous physical activity enhances cognition.ObjectiveThis study examines whether physical activity moderates the relationship between systemic inflammation and cognitive performance.MethodsWe analyzed 24,661 adults (50+) from the Dutch Lifelines cohort across two waves. Cognitive performance was assessed via a validated composite score from the Cogstate Brief Battery, with higher scores indicating lower cognitive performance. Leukocyte count (3-11 × 109 cells/liter) served as a systemic inflammation biomarker, categorized as low (<6.5 × 109 cells/liter) or high (≥6.5 × 109 cells/liter). We used the Short Questionnaire to Assess Health-Enhancing Physical Activity to define moderate (0, 1-149, 150+ minutes) and vigorous (0, 1-74, 75+ minutes) physical activity. We performed linear regression models to examine the effect of inflammation and vigorous physical activity on cognition, adjusting for moderate physical activity and covariates. An interaction effect analyzed the potential moderation of vigorous physical activity.ResultsIndividuals with high systemic inflammation (SI) levels in both waves exhibited significantly longer reaction times (b = 0.062 [95% confidence interval: 0.002; 0.122]) compared to those with low SI levels in both waves. Individuals who engaged in 1-74 min or 75+ minutes of vigorous physical activity had significantly faster reaction times (1-74: b = -0.114 [-0.193; -0.034], 75+: b = -0.160 [-0.210; -0.111]) than those who did not. The interaction term was insignificant.ConclusionsAlthough vigorous physical activity is protective, it cannot mitigate the negative association between systemic inflammation and cognition. Nevertheless, promoting vigorous physical activity in an ageing population can be an effective strategy for preventing or delaying cognitive decline.
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Alzheimer's disease
|2 Other
650 _ 7 |a cognitive performance
|2 Other
650 _ 7 |a cohort study
|2 Other
650 _ 7 |a physical activity
|2 Other
650 _ 7 |a systemic inflammation
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Netherlands: epidemiology
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Inflammation: psychology
|2 MeSH
650 _ 2 |a Inflammation: epidemiology
|2 MeSH
650 _ 2 |a Exercise: physiology
|2 MeSH
650 _ 2 |a Exercise: psychology
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Cognition: physiology
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Independent Living: psychology
|2 MeSH
650 _ 2 |a Cohort Studies
|2 MeSH
650 _ 2 |a Neuropsychological Tests
|2 MeSH
650 _ 2 |a Cognitive Dysfunction
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Aging in Place
|2 MeSH
700 1 _ |a Reinke, Constantin
|0 0000-0003-3228-1794
|b 1
700 1 _ |a Aretz, Benjamin
|0 0000-0003-0143-0873
|b 2
700 1 _ |a Heneka, Michael T
|0 P:(DE-2719)2000008
|b 3
700 1 _ |a Doblhammer, Gabriele
|0 P:(DE-2719)2811246
|b 4
|e Last author
773 _ _ |a 10.1177/13872877251386480
|g Vol. 108, no. 3, p. 1369 - 1377
|0 PERI:(DE-600)2070772-1
|n 3
|p 1369 - 1377
|t Journal of Alzheimer's disease
|v 108
|y 2025
|x 1387-2877
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/282554/files/DZNE-2025-01317.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/282554/files/DZNE-2025-01317.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:282554
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2241493
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2811246
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-20
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-20
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-20
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-20
920 1 _ |0 I:(DE-2719)1012002
|k AG Doblhammer
|l Demographic Studies
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1012002
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21